Navigation Links
Raptor Pharmaceuticals Corp. and TorreyPines Complete Merger
Date:9/30/2009

mprove liquidity in our common stock and improve our access to the capital markets. In the coming months, we hope to announce several important milestones. By the end of 2009, we expect to announce clinical trial data on our lead product candidate, DR Cysteamine, from a Phase 2a clinical trial in non-alcoholic steatohepatitis ("NASH") and a Phase 2b clinical trial in nephropathic cystinosis ("cystinosis")."

In connection with the exchange of shares in the merger, Raptor and TorreyPines stockholders will own 95% and 5% of the outstanding shares of the combined company, respectively. Raptor stockholders will receive 17,881,300 shares of the combined company's common stock in exchange for the 76,703,147 shares of Raptor common stock outstanding immediately prior to the closing of the merger. TorreyPines stockholders will receive 941,121 shares of the combined company's common stock in exchange for the 15,999,058 shares of TorreyPines common stock outstanding immediately prior to the closing of the merger. For example:


                                          1,000 Shares of    1,000 Shares of
                                              Raptor           TorreyPines
                                          ---------------    ---------------
    Number of Combined Company Shares
     Issued as a Result of Merger              233                 58


In connection with the merger and subject to the same conversion factor as the Raptor common stock, the combined company will assume all of Raptor's stock options and warrants outstanding at the time of the merger. The combined company will also retain the TorreyPines stock options and warrants outstanding at the merger, subject to the same conversion factor as the TorreyPines common stock.

About Raptor Pharmaceutical Corp.

Raptor Pharmaceutical Corp. ("the Company") is dedicated to speeding the de
'/>"/>

SOURCE Raptor Pharmaceuticals Corp.; TorreyPines Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Raptor Pharmaceuticals Receives Notices of Allowance for Two NeuroTrans(TM) Patent Applications
2. Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer
3. Raptor Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2a Clinical Trial in Non-Alcoholic Steatohepatitis (NASH)
4. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
5. Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire dAngers for Phase II Clinical Trial in Huntingtons Disease
6. Raptor Pharmaceuticals Provides Update on Targeting Platforms
7. Raptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation in Non-Alcoholic Steatohepatitis (NASH)
8. Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
9. Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)
10. Raptor Pharmaceuticals Provides Update of Product Programs
11. Arena Pharmaceuticals Reports Positive, Highly Significant BLOSSOM Trial Results for Weight Management; NDA Submission on Track for December
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... BOSTON , Sept. 16, 2014 QPID ... a move to new headquarters in Boston ... The new headquarters will be at 175 Franklin Street in ... operations and marketing teams. QPID Health,s new Southern ... Parkway in Carlsbad.  The expansion will help meet the demands ...
(Date:9/16/2014)... , Sept. 16, 2014  Decision Resources Group finds that the ... billion in 2013 to over $18.2 billion in 2023 in ... Germany , Italy , ... and Japan . TNF-alpha inhibitors will remain the ... RA market, but growth will be constrained and patient shares will ...
(Date:9/16/2014)... 2014  Formex, LLC ("Formex"), a leader in ... Weilersbacher joined Formex as Director of Quality ... Greg Weilersbacher has over 20 ... in Quality Assurance, Facility Validation, GMP manufacturing, and ... to Formex a diverse wealth of experience. ...
Breaking Medicine Technology:QPID Health Announces Major Office Expansion in Boston and Opens Facility in San Diego 2The Rheumatoid Arthritis Drug Market Will Grow to $18.2 Billion in 2023, Driven by the Uptake of Oral Jak Inhibitors and Non TNF-alpha Biologics 2The Rheumatoid Arthritis Drug Market Will Grow to $18.2 Billion in 2023, Driven by the Uptake of Oral Jak Inhibitors and Non TNF-alpha Biologics 3Greg Weilersbacher Joins Formex, LLC As Director of Quality Assurance and Quality Control 2
(Date:9/16/2014)... September 16, 2014 Who:, The Pulmonary ... Medical Campus and Children’s Hospital Colorado are ... the country’s leading pulmonary hypertension association that works to find ... disease of the lungs that affects the functioning of the ... mean survivability is only 2.8 years. , What:, Colorado ...
(Date:9/16/2014)... September 16, 2014 As part of ... Latin American Citizens (LULAC) will host the second annual ... Salud will feature free health screenings for osteoporosis, HIV, ... includes glucose and cholesterol levels as well as bone ... for children under 6 years old , The event ...
(Date:9/16/2014)... 16, 2014 (HealthDay News) -- Including women older than ... to a sharp reduction in advanced forms of the ... breast cancer screening programs could result in older women ... So, the decision to screen older women for breast ... recommended. "Instead of using mass screening, the decision ...
(Date:9/16/2014)... HealthDay Reporter TUESDAY, Sept. ... cancer survivors are alive today, compared to just 3 ... reported Tuesday. These individuals amount to 4 percent ... childhood cancer, according to the association,s annual progress report. ... treatment of cancer and details some of the challenges ...
(Date:9/16/2014)... for Radiation Oncology (ASTRO) has selected C.M. Charlie Ma, ... Oncology, and Director of Medical Physics at Fox ... The distinguished members selected to receive the Fellow of ... on Tuesday, September 16, at the ASTRO,s 56th Annual ... Fellows designation is a great honor and we are ...
Breaking Medicine News(10 mins):Health News:Help Fight Pulmonary Hypertension at the Colorado PH in the Park 2014 2Health News:LULAC Hosts Second Annual Latinos Living Healthy Feria de Salud in Los Angeles 2Health News:Some Benefits of Screening Elderly Women for Breast Cancer Questioned 2Health News:Targeted Drugs Among Successes Against Cancer, Says New Report 2Health News:Targeted Drugs Among Successes Against Cancer, Says New Report 3Health News:Targeted Drugs Among Successes Against Cancer, Says New Report 4
... A new UC Irvine study finds that lithium chloride, ... the development of inclusion body myositis, a skeletal muscle ... by scientists Frank LaFerla and Masashi Kitazawa, mice genetically ... six months after receiving daily doses of lithium chloride, ...
... Go,Healthcare, Inc. (OTC Bulletin Board: OGOH; ,OTG, ,the ... integrator,announced today that after more than four industry ... Value Added Reseller (,VAR,),business unit to Tampa, FL ... of the sale, in the amount of $4 ...
... to scenic attractions, COLUMBIA, S.C., March 18 ... Costa Rica for care now have a convenient ... farms, biological reserves,and other breathtaking scenery while awaiting ... division of Columbia, S.C.-based Companion,Global Healthcare Inc., has ...
... study appearing in the March 2008 issue of the ... natural family planning method developed by researchers from Georgetown ... women to family planning. More than half the women ... used family planning and on average, contraceptive use increased ...
... DALLAS, March 18 Phoenix Health Systems, a ... on the,business goals of healthcare organizations, announced today ... Management Services, Inc.,(TMSI) has awarded Phoenix Health Systems, ... TMSI performs considerable due diligence to,make certain the ...
... N.J., March 18 Barr,Pharmaceuticals, Inc. (NYSE: ... (LSE: PLVD), sent Notice to Deutsche Bank, acting ... Deposit Agreement (the "Deposit,Agreement") effective June 19, 2008 ... PLIVA will seek to delist from the London,Stock ...
Cached Medicine News:Health News:Lithium chloride slows onset of skeletal muscle disorder 2Health News:Lithium chloride slows onset of skeletal muscle disorder 3Health News:On The Go Healthcare Sells VAR Business to Wireless and Internet Space Development Leader FTS Group 2Health News:On The Go Healthcare Sells VAR Business to Wireless and Internet Space Development Leader FTS Group 3Health News:On The Go Healthcare Sells VAR Business to Wireless and Internet Space Development Leader FTS Group 4Health News:Companion Global Dental Clients Have New Reason to Smile in Costa Rica 2Health News:New choices bring wider range of women to family planning 2Health News:Texas Organization of Rural and Community Hospitals (TORCH) Awards Phoenix Health Systems Endorsed Vendor Status 2Health News:Barr's PLIVA Subsidiary to Terminate GDR Deposit Agreement and Delist From London Stock Exchange 2Health News:Barr's PLIVA Subsidiary to Terminate GDR Deposit Agreement and Delist From London Stock Exchange 3Health News:Barr's PLIVA Subsidiary to Terminate GDR Deposit Agreement and Delist From London Stock Exchange 4
Ungrooved permanent silicone strip. Indications: For trapdoor procedure. Overall length: 125 mm, 4.9 inches....
Ungrooved permanent silicone strip. Indications: For trapdoor procedure. Overall length: 125 mm, 4.9 inches....
Used with Double Tantalum Clip (250 style) E5381 852. Overall length: 7.0 mm....
Concave inner surface to conform to the globe. Indications: Wide scleral bed. Outside diameter 32 mm....
Medicine Products: